Zhejiang Cancer Hospital
In research, Zhejiang Cancer Hospital stands highest in Life Sciences (#502 of 7,800 worldwide), Medicine (#739 of 10,443 worldwide) and Health Sciences (#890 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Pulmonary and Respiratory Medicine — Cancer Research is 12.8× its share of world research.
- World rank, 2022–2025
- #1,323 of 28,054 · #3,922 all time
- Rank in China
- #392 of 3,058
- Research works
- 4k ▼ 4% vs 2013–17
- Citations
- 54k 13.7 per fractional work
- Top-10% rate
- 27.0% record average 16.5%
- Open access
- 51% world 28%
What is Zhejiang Cancer Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #502 of 7,800 | 32.0% | 408 | #1695 | |
| MedicineField | #739 of 10,443 | 23.4% | 692 | #1575 | |
| Health SciencesDomain | #890 of 11,982 | 23.5% | 732 | #1964 | |
| Biochemistry, Genetics and Molecular BiologyField | #458 of 3,579 | 31.1% | 329 | #1602 | |
| Molecular BiologySubfield | #346 of 2,175 | 31.0% | 207 | #1197 | |
| OncologySubfield | #127 of 772 | 24.1% | 183 | #424 | |
| Pulmonary and Respiratory MedicineSubfield | #325 of 1,144 | 18.9% | 143 | #883 | |
| SurgerySubfield | #613 of 1,816 | 22.9% | 75 | #1394 | |
| Physical SciencesDomain | #4,437 of 12,888 | 31.0% | 117 | #9218 | |
| Cancer ResearchSubfield | #120 of 237 | 30.5% | 71 | #375 |
Each strip is that field’s whole ranked pool, with the notch where Zhejiang Cancer Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#1,695 #502
- Medicine#1,575 #739
- Health Sciences#1,964 #890
- Biochemistry, Genetics and Molecular Biology#1,602 #458
- Molecular Biology#1,197 #346
- Oncology#424 #127
- Pulmonary and Respiratory Medicine#883 #325
- Surgery#1,394 #613
- Physical Sciences#9,218 #4,437
- Cancer Research#375 #120
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Zhejiang Cancer Hospital specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 12.8× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 70.6 works13×
- OncologySubfield · 182.6 works13×
- Pulmonary and Respiratory MedicineSubfield · 143.0 works7.3×
- ImmunologySubfield · 48.2 works5.5×
- Molecular BiologySubfield · 206.9 works5.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.9×
- Dentistry 4.4×
- Immunology and Microbiology 4.0×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Neuroscience 0.7×
- Chemistry 0.7×
- Materials Science 0.6×
- Nursing 0.5×
- Health Professions 0.3×
- Physics and Astronomy 0.3×
- Engineering 0.2×
- Chemical Engineering 0.2×
- Energy 0.1×
- Computer Science 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.1×
- Veterinary 0.1×
- Economics, Econometrics and Finance 0.1×
- Mathematics 0.0×
- Arts and Humanities 0.0×
- Decision Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Zhejiang Cancer Hospital?
Ranked on the composite score, Jiang‐Jiang Qin, Jieer Ying and Xiangdong Cheng lead among researchers whose main affiliation is Zhejiang Cancer Hospital.
- 1 Jiang‐Jiang Qin China · #123,781 worldwide 139 citations · 26 works
- 2 Jieer Ying China · #130,460 worldwide 501 citations · 20 works
- 3 Xiangdong Cheng China · #190,511 worldwide 93 citations · 28 works
- 4 Baiyong Li China · #200,696 worldwide 97 citations · 24 works
- 5 Ming Chen China · #374,978 worldwide 294 citations · 172 works
- 6 Hongjian Yang China · #514,064 worldwide 48 citations · 19 works
- 7 Tianhui Chen China · #523,591 worldwide 114 citations · 27 works
- 8 Zhiyuan Xu China · #685,783 worldwide 53 citations · 17 works
- 9 Xiaojia Wang China · #690,265 worldwide 97 citations · 38 works
- 10 Jianqing Zhu China · #704,641 worldwide 47 citations · 41 works
Which keywords describe research at Zhejiang Cancer Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Tumor Microenvironment, Immunotherapy, Clinical Trials, Targeted Therapy, Metastasis and Clinical Practice Guidelines.
- Tumor Targeting
- GPX4
- PET Imaging
- EGFR Mutations
- Lipid Peroxidation
- Treatment Guidelines
- Tumor Markers
- Molecular Characterization
- Endoscopic Resection
- Immune Checkpoint Blockade
- Immunity
- Precision Medicine
- Cell Death
- Gene Expression
- Biomarkers
- Clinical Practice Guidelines
- Metastasis
- Clinical Trials
- Immunotherapy
- Chemotherapy
- Cancer
- Tumor Microenvironment
- Inflammation
- Targeted Therapy
- Oxidative Stress
- Cancer Therapy
- Prognostic Factors
- Radiotherapy
- Survival Analysis
- Neoadjuvant Therapy
- Adjuvant Therapy
- PD-1 and PD-L1
- Breast Cancer
- Apoptosis
- Cancer Progression
- Genomic Profiling
- ALK Inhibitors
- Epigenetic Regulation
- Ferroptosis
- Gastric Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer149▲ 8.7×52 topics
- Chemotherapy140▲ 16×22 topics
- Tumor Microenvironment110▲ 20×8 topics
- Immunotherapy88▲ 9.8×17 topics
- Inflammation88▲ 3.3×75 topics
- Clinical Trials67▲ 7.9×16 topics
- Targeted Therapy66▲ 23×5 topics
- Metastasis64▲ 15×12 topics
- Oxidative Stress63▲ 3.0×51 topics
- Clinical Practice Guidelines62▲ 8.9×14 topics
- Cancer Therapy57▲ 7.9×19 topics
- Biomarkers57▲ 6.5×15 topics
- Prognostic Factors56▲ 10×14 topics
- Gene Expression56▲ 7.3×19 topics
- Radiotherapy54▲ 11×12 topics
- Cell Death44▲ 15×6 topics
- Survival Analysis44▲ 13×6 topics
- Precision Medicine43▲ 7.2×8 topics
- Neoadjuvant Therapy42▲ 14×5 topics
- Immunity39▲ 7.6×10 topics
- Adjuvant Therapy39▲ 24×2 topics
- Immune Checkpoint Blockade37▲ 26×1 topic
- PD-1 and PD-L137▲ 26×1 topic
- Endoscopic Resection36▲ 29×2 topics
- Breast Cancer36▲ 12×10 topics
- Molecular Characterization33▲ 15×6 topics
- Apoptosis31▲ 8.1×19 topics
- Tumor Markers30▲ 29×2 topics
- Cancer Progression30▲ 13×8 topics
- Treatment Guidelines29▲ 11×7 topics
- Genomic Profiling28▲ 22×2 topics
- Lipid Peroxidation26▲ 20×3 topics
- ALK Inhibitors26▲ 33×1 topic
- EGFR Mutations26▲ 33×1 topic
- Epigenetic Regulation26▲ 9.6×6 topics
- PET Imaging26▲ 12×5 topics
- Ferroptosis26▲ 27×1 topic
- GPX426▲ 27×1 topic
- Gastric Cancer26▲ 18×3 topics
- Tumor Targeting25▲ 11×3 topics
Which research topics does Zhejiang Cancer Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Ferroptosis and cancer prognosis and Lung Cancer Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 37 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 26 works
- 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 26 works
- 4 Lung Cancer Research Studies Oncology 23 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 21 works
- 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 20 works
- 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 19 works
- 8 Advanced biosensing and bioanalysis techniques Molecular Biology 17 works
- 9 RNA modifications and cancer Molecular Biology 17 works
- 10 Esophageal Cancer Research and Treatment Surgery 16 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Zhejiang Cancer Hospital's research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hangzhou
- Zhejiang University
- Zhejiang University of Technology
- Hangzhou Dianzi University
- Zhejiang Sci-Tech University
- China Jiliang University
- Hangzhou Normal University
- Zhejiang Chinese Medical University
- Zhejiang Gongshang University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.